Moderators and Mediators of Treatment Outcome for Youth With ADHD: Understanding for Whom and How Interventions Work

Ambulatory Pediatrics

Volumn 7, Issue 1 SUPPL., 2007, Pages 91-100

  Hinshaw, Stephen P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADHD; mediator; moderator

Indexed keywords

CENTRAL STIMULANT AGENT; PLACEBO;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; HUMAN; INTELLIGENCE QUOTIENT; MEDICAL RESEARCH; METHODOLOGY; PARENTAL BEHAVIOR; PEER GROUP; REVIEW; SOCIAL INTERACTION; SOCIAL SUPPORT; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; MALE; TREATMENT OUTCOME;

EID: 33846431268     PISSN: 15301567     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ambp.2006.04.012     Document Type: Review

References (38)

1. Mannuzza S., and Klein R.G. Adolescent and adult outcome in attention-deficit/hyperactivity disorder. In: Quay H.C., and Hogan A.E. (Eds). Handbook of Disruptive Behavior Disorders (1999), Kluwer Academic/Plenum, New York, NY 279-294
2. Jensen P.S., Weersing R., Hoagwood K.E., and Goldman E. What is the evidence for evidence-based treatments? A hard look at our soft underbelly. Ment Health Serv Res 7 (2005) 53-74
3. Hinshaw S.P. Intervention research, theoretical mechanisms, and causal processes related to externalizing behavior patterns. Dev Psychopathol 14 (2002) 789-818
4. Kazdin A.E., and Nock M.K. Delineating mechanisms of change in child and adolescent therapy: methodological issues and research recommendations. J Child Psychol Psychiatry 44 (2003) 1116-1129
5. Paul G.L., and Lentz R.J. Psychosocial Treatment of Chronic Mental Patients: Milieu vs Social-Learning Paradigms (1977), Harvard University Press, Cambridge, Mass
6. Hinshaw S.P. Is ADHD an impairing condition in childhood and adolescence?. In: Jensen P.S., and Cooper J.R. (Eds). Attention-Deficit Hyperactivity Disorder: State of the Science, Best Practices (2002), Civic Research Institute, Kingston, NJ 5-1-5-21
7. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 (1986) 1173-1182
8. Kraemer H.C., Stice E., Kazdin A.E., et al. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 158 (2001) 848-856
9. Kraemer H.C., Wilson G.T., Fairburn C.G., and Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 69 (2002) 877-884
10. McClelland G.H., and Judd C.M. Statistical difficulties of detecting interactions and moderator effects. Psychol Bull 114 (1993) 376-390
11. MacKinnon D.P., Lockwood C.M., Hoffman J.M., et al. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 7 (2002) 83-104
12. Holmbeck G.N. Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. J Pediatr Psychol 27 (2002) 87-96
13. Owens E.B., Hinshaw S.P., Kraemer H.C., et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol 71 (2003) 540-552
14. Swanson J.M., Kraemer H.C., Hinshaw S.P., et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40 (2001) 168-179
15. MTA Cooperative Group. Fourteen-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 56 (1999) 1073-1086
16. Smeraldi E., Zanardi R., Benedetti F., et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3 (1998) 508-511
17. Hinshaw S.P., Owens E.B., Wells K.C., et al. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol 28 (2000) 555-568
18. Costello E.J., Compton S.N., Keeler G., and Angold A. Relationships between poverty and psychopathology: a natural experiment. JAMA 290 (2003) 2023-2029
19. Eddy J.M., and Chamberlain P. Family management and deviant peer association as mediators of the impact of treatment condition on youth antisocial behavior. J Consult Clin Psychol 68 (2000) 857-863
20. Howe G.W., Reiss D., and Yuh J. Can prevention trials test theories of etiology?. Dev Psychopathol 14 (2002) 673-694
21. Hinshaw S.P., Klein R., and Abikoff H. Nonpharmacologic treatments and their combination with medication. In: Nathan P.E., and Gorman J. (Eds). A Guide to Treatments That Work. 2nd ed. (2002), Oxford University Press, New York, NY 3-23
22. Arnold L.E., Abikoff H., Cantwell D.P., et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children With ADHD (MTA): clinical design challenges and choices. Arch Gen Psychiatry 54 (1997) 865-870
23. Hinshaw S.P., March J.S., Abikoff H., et al. Comprehensive assessment of childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial. J Atten Disord 1 (1997) 217-234
24. Richters J.E., Arnold L.E., Jensen P.S., et al. The National Institute of Mental Health Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit Hyperactivity Disorder (MTA): I. Background and rationale. J Am Acad Child Adolesc Psychiatry 34 (1995) 987-1000
25. Conners C.K., Epstein J.N., March J.S., et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 40 (2001) 159-167
26. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit hyperactivity disorder. Pediatrics 113 (2004) 754-761
27. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness of and growth after the end of treatment. Pediatrics 113 (2004) 762-770
28. MTA Cooperative Group. Moderators and mediators of treatment response for children with ADHD: the MTA Study. Arch Gen Psychiatry 56 (1999) 1088-1096
29. Hinshaw S.P., and Blachman D.R. Attention-deficit/hyperactivity disorder. In: Bell-Dolan D., Foster S., and Mash E.J. (Eds). Handbook of Behavioral and Emotional Problems in Girls (2005), Kluwer Academic/Plenum, New York, NY 117-147
30. Jensen P.S., Hinshaw S.P., Kraemer H.C., et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40 (2001) 147-158
31. March J.S., Swanson J.M., Arnold L.E., et al. Anxiety as a predictor and outcome variable in the Multimodal Treatment of Children With ADHD (MTA). J Abnorm Child Psychol 28 (2000) 527-541
32. Arnold L.E., Elliott M., Sachs L., et al. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol 71 (2003) 713-727
33. Jensen P.S., Hoagwood K.E., Roper M., et al. The Services for Children and Adolescents Parent Interview (SCAPI): development and performance characteristics. J Am Acad Child Adolesc Psychiatry 43 (2004) 1334-1344
34. Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 29 (1998) 65-99
35. Johnston C., and Mash E.J. Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clin Child Fam Psychol Rev 4 (2001) 183-207
36. Campbell S.B. Behavior Problems in Preschool Children. 2nd ed. (2002), Guilford Press, New York, NY
37. Kazdin A.E., and Weisz J.R. Evidence-Based Psychotherapies for Children and Adolescents (2003), Guilford, New York, NY
38. Weersing V.R., and Weisz J.R. Mechanisms of action of youth psychotherapy. J Child Psychol Psychiatry 43 (2002) 3-29